Does amyloid enhancing factor (AEF) exist? Is AEF a single biological entity?

References

• Werdelin O, Ranlov P. Amyloidosis in mice produced by transplantation of spleen cells from caseintreated mice. Acta Pathol Microbiol Scand. 1966; 68: 1–18
   PubMedGoogle Scholar
• Hardt F. Transfer amyloidosis. Amer J Pathol. 1971; 65: 411–424
   PubMed Web of Science ®Google Scholar
• Hardt F, Ranlov P. Transfer amyloidosis. Int Rev Exp Pathol 1976; 16: 273–334
   PubMedGoogle Scholar
• Jakob W, Hilgenfeld M, Karasek E. Beschleunigte Amyloidbildung bei Musen durch Milzzellkulturen. Exp Pathol 1972; 6: 141–144
   Google Scholar
• Keizman J, Rimon A, Sohar E, Gafni J. Amyloid accelerating factor: purification of a substance from human spleen that accelerates the formation of casein induced murine amyloid. Path Microbiol. 1972; S233: 172–177
   Google Scholar
• Kedar I, Bleiberg J, Sohar E. Stimulation of murine amyloidosis by a dialyzable product from pretreated donors. Brit J Exp Pathol 1975; 56: 244–246
   PubMedGoogle Scholar
• Axelrad M A, Kisilevsky R, Willmer J, Chen S J, Skinner M. Further characterization of amyloid enhancing factor. Lab Invest 1982; 47: 139–146
   PubMed Web of Science ®Google Scholar
• Axelrad M A, Kisilevsky R, Beswetherick S. Acceleration of amyloidosis by syngeneic spleen cells from normal donors. Amer J Pathol 1975; 78: 277–284
   PubMed Web of Science ®Google Scholar
• Janigan D T, Druet R L. Experimental amyloidosis: role of antigenicity and rapid induction. Amer J Pathol 1966; 48: 1013–1025
   PubMedGoogle Scholar
• Janigan D T, Druet R L. The role of the immunologic apparatus in the pathogenesis of experimental amyloidosis. Isr J Med Sci 1968; 4: 1035–1043
   Google Scholar
• Kisilevsky R, Axelrad M A, Corbett W EN, Brunet S, Scott F. The role of inflammatory cells in the pathogenesis of amyloidosis. Lab Invest 1977; 37: 544–553
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Axelrad M A, Brunet S, Richards M. Effects of amyloid induction on plasma protein turnover and its implications. Amer J Pathol 1976; 83: 299–318
   PubMedGoogle Scholar
• Baltz M L, Caspi D., Hind C RK, Feinstein A, Pepys M B. Isolation and characterization of amyloid enhancing factor (AEF). Amyloidosis, G G Glenner, E F Osserman, E P Benditt, E Calkins, A S Cohen, D Zucker-Franklin. Plenum Press, New York, New York 1986; 115–121
   Google Scholar
• Niewold Th A, Hol P R, van Andel A CJ, Lutz E TG, Gruys E. Enhancement of amyloid induction by amyloid fibril fragments in hamster. Lab Invest 1987; 56: 544–549
   PubMed Web of Science ®Google Scholar
• Hol P R, van Andel A CJ, van Ederen J, Draayer J, Gruys E. Amyloid enhancing factor in hamster. Brit J Exp Pathol 1985; 66: 689–697
   PubMedGoogle Scholar
• Hol P R, Snel F WJJ, Niewold Th A, Gruys E. Amyloid enhancing factor (AEF) in the pathogenesis of AA-amyloidosis in the hamster. Virchows Arch B Cell Pathol 1986; 52: 273–281
   Google Scholar
• Gruys E, Snel F WJJ. Animal models for reactive amyloidosis. Clinical Rheumatology Vol. 8 No. 3. Reactive Amyloidosis and the Acute Phase Response, G. Husby. Bailliere Tindall, London 1994; 599–611
   Google Scholar
• Prelli F, Pras M, Shtrasburg S, Frangione B. Characterization of high molecular weight amyloid-A proteins. Scand J Immunol 1991; 33: 783–786
   PubMed Web of Science ®Google Scholar
• Veiby O P, Sletten K, Husby G, Nordstoga K. Amino acid sequence analyses of non-AA proteins from amyloid fibrils of bovine kidney. Scand J Immunol 1992; 35: 63–69
   PubMed Web of Science ®Google Scholar
• Alizadeh-Khiavi K, Normand J, Chronopoulos S, Ali Khan Z. Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity - behavior of ubiquitin during accelerated amyloidogenesis. Acta Neurolpathol 1991; 81: 280–286
   PubMedGoogle Scholar
• Chronopoulos S, Alizadeh-Khiavi K, Normand J, Ali-Khan Z. Binding of ubiquitin to experimentally induced murine-AA amyloid. J Pathol 1991; 163: 199–203
   PubMed Web of Science ®Google Scholar
• Alizadeh-Khiavi K, Normand J, Chronopoulos S, Ali A, Ali-Khan Z. Amyloid enhancing factor activity is associated with ubiquitin. Virchows Arch[A] 1992; 420: 139–148
   Google Scholar
• Ali-Khan Z, Norman J., Alizadeh-Khiavi K, Robitaille Y, Chronopoulos S. Ubiquitin profile and amyloid enhancing factor activity in Alzheimer and normal human brain extracts. Neurosci Lett 1992; 139: 24–28
   PubMed Web of Science ®Google Scholar
• Chronopoulos S, Lembo P, Alizadeh-Khiavi K, Ali-Khan Z. Ubiquitin - its potential significance in murine AA amyloidogenesis. J Pathol 1992; 167: 249–259
   PubMed Web of Science ®Google Scholar
• Gervais F, Morrissette C, Frangione B. AEF extraction from brain of patients with Alzheimer's disease is associated with MPB. Amyloid and Amyloidosis 1993, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. The Parthenon Publishing Group, Pearl River, New York 1994; 168–170
   Google Scholar
• Shirahama T, Abraham C R, Ju S T, Miura K, Cohen A S, Kisilevsky R, Gruys E. Isolation of a 16kD fraction with extremely high AEF activity. Amyloid and Amyloidosis 1990, J B Natvig, O Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, Dordrecht 1991; 288–291
   Google Scholar
• Niewold T A, Gruys E., Kisilevsky R, Shirahama T S. Fibril amyloid enhancing factor (FAEF)-accelerated amyloidosis in the hamster is not dependent on serine esterase activity and mononuclear phagocytosis. Scand J Immunol 1991; 34: 101–107
   PubMed Web of Science ®Google Scholar
• Deal C L, Sipe J D, Tatsuta E, Skinner M, Cohen A S. The effect of amyloid enhancing factor (AEF) on the acute phase serum amyloid A (SAA) and serum amyloid P (SAP) response to silver nitrate. Ann NY Acad Sci. 1982; 389: 439–441
   Web of Science ®Google Scholar
• Varga J, Flinn M S, Shirahama T, Rodgers O G, Cohen A S. The induction of accelerated murine amyloid with human splenic extract. Probable role of amyloid enhancing factor. Virchows Arch B Cell Pathol. 1986; 51: 177–185
   Google Scholar
• Ali-Khan Z, Quriion R., Robitaille Y., Alizadeh-Khiavi K, Du T. Evidence for increased amyloid enhancing factor activity in Alzheimer brain extract. Acta Neuropathol 1988; 77: 82–90
   PubMed Web of Science ®Google Scholar
• Ganowiak K, Hultman P, Engstrom U., Gustavsson A, Westermark P. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Bochem Biophys Res Commun 1994; 199: 306–312
   PubMed Web of Science ®Google Scholar
• Niewold T A, Gruys E, Arakawa T., Shirahama T, Kisilevsky R. Recombinant human tumour necrosis factor-alpha (rhTNF-alpha) and rhTNF-alpha analogue enhance amyloid deposition in the Syrian hamster. Scand J Immunol 1991; 37: 29–32
   Google Scholar
• Vijay-Kumar S, Bugg C E, Wilkinson K D, Cook W J. Three-dimensional structure of ubiquitin at 2.8 A resolution. Proc Natl Acad Sci USA. 1985; 82: 3582–3585
   PubMed Web of Science ®Google Scholar
• Vijay-Kumar S, Bugg C E, Cook W J. Structure of ubiquitin refined at 1.8 A resolution. J Mol Biol 1987; 194: 531–544
   PubMed Web of Science ®Google Scholar
• Cathcart E S, Sipe J D, Gonnerman W A, Carreras I, de Beer M C, de Beer F C. Amyloid resistance in the CE/J mouse. Amyloid and Amyloidosis 1993, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. The Parthenon Publishing Group, Pearl River, New York 1994; 29–31
   Google Scholar
• Sipe J D, Carreras I, Gonnerman W A, Cathcart E S, de Beer M C, de Beer F C. Characterization of the inbred CE/J mouse strain as amyloid resistant. Amer J Pathol 1993; 143: 1480–1485
   PubMed Web of Science ®Google Scholar
• Kandel R, Gonnerman W A, Sipe J D, Greene L, Cathcart E S. AEF produced by amyloid-resistant CE/J mice. Amyloid and Amyloidosis 1993, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckl, I D Young. Parthenon Publishing Group, Pearl River 1994; 122–124
   Google Scholar
• Kelly J W, Lansbury P T. A chemical approach to elucidate the mechanism of transthyretin and β-protein amyloid fibril formation. Amyloid Int J Exp Clin Invest 1994; 1: 186–205
   Web of Science ®Google Scholar
• Barrow C J, Yasuda A, Kenny P TM, Zagorski M G. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease - analysis of circular dichroism spectra. J Mol Biol 1992; 225: 1075–1093
   PubMed Web of Science ®Google Scholar
• Games D, Khan K M, Soriano F G, Keim P S, Davis D L, Bryant K, Lieberburg I. Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain. Neurobiol Aging 1992; 13: 569–576
   PubMed Web of Science ®Google Scholar
• Araki S, Yi S, Murakami T, Watanabe S, Ikegawa S, Takahashi K, Yamamura K. Systemic amylcidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene - pathological and immunohistochemical similarity to human familial amyloidotic polyneuropathy, Type I. Mol Neurobiol 1994; 8: 15–23
   Google Scholar
• Stahl N, Prusiner S B. Prions and prion proteins. FASEB J 1991; 5: 2799–2807
   PubMed Web of Science ®Google Scholar
• Gajdusek D C. Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses. Mol Neurobiol 1994; 8: 1–13
   Google Scholar
• Cohen F E, Pan K M, Huang Z, Baldwin R U, Prusiner S B. Structural clues to prion replication. Science 1994; 264: 530–531
   PubMed Web of Science ®Google Scholar
• Abankwa G V, Ali-Khan Z. Alveolar hydatid cyst induced amyloid enhancing factor (AEF): physico-chemical properties and abolition of AEF activity by serine protease inhibitors. Brit J Exp Pathol 1988; 69: 133–148
   PubMedGoogle Scholar
• Hol P R, van Ederen A M, Snel F WJJ, Langeveld J PM, Veerkamp J H, Gruys E. Activities of lysosomal enzymes and levels of serum amyloid A (SAA) in blood plasma of hamsters during casein induction of AA-amyloidosis. Brit J Exp Pathol 1985; 69: 279–292
   Google Scholar
• Stone P J, Campistol J M, Abraham C R, Rodgers O, Shirahama T, Skinner M. Neutrophil proteases associated with amyloid fibrils. Biochem Biophys Res Commun 1993; 197: 130–136
   PubMedGoogle Scholar
• Yokota T, Ishihara T, Kawano H, Takahashi M, Fujinaga H, Uchino F. Amyloid enhancing factor (AEF) in the aging mouse. Virchows Arch A Pathol Anat Histopathol 1989; 414: 511–514
   PubMedGoogle Scholar
• Baumal R. Similarity of casein-and endotoxin-in-duced, myeloma-associated and aged SJL/J amyloid in various strains of mice. Int Arch Allergy App Immunol 1979; 59: 20–27
   Google Scholar
• Moog F. The small intestine in old mice: growth, alkaline phosphatase and disaccharidase activities, and deposition of amyloid. Exp Gerontol 1977; 12: 223–235
   Google Scholar
• Naiki H, Higuchi K, Yonezu T, Hosokawa M, Takeda T. Metabolism of senile amyloid precursor and amyloidogenesis: Age-related acceleration of apolipoprotein A-II clearance in the Senescence Accelerated Mouse. Amer J Pathol 1988; 130: 579–587
   Google Scholar
• Picken M M, Gallo G R, Frangione B. Amyloid enhancing factor and inflammatory reaction. Lab Invest 1990; 63: 586–587
   PubMedGoogle Scholar
• Kisilevsky R, Boudreau L. The kinetics of amyloid deposition: I. The effect of amyloid enhancing factor and splenectomy. Lab Invest 1983; 48: 53–59
   PubMed Web of Science ®Google Scholar
• Shirahama T, Miura K, Ju S T, Kisilevsky R, Gruys E, Cohen A S. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab Invest 1990; 62: 61–68
   PubMed Web of Science ®Google Scholar
• Miura K, Baba S, Shirasawa H, Ju S T, Cohen A S, Shirahama T. Intraperitoneal amyloid formation by amyloid enhancing factor rich macrophages in ascitic fluid. Amyloid and Amyloidosis 1990, J B Natvig, O Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, Dordrecht 1991; 523–526
   Google Scholar
• Wohlgethan J, Cathcart E S. Amyloid resistance in A/J mice: Studies with a transfer model. Lab Invest 1980; 42: 663–667
   PubMedGoogle Scholar
• Wohlgethan J R, Cathcart E S. Amyloid resistance in A/J mice is determined by a single gene. Nature 1979; 278: 453–454
   PubMedGoogle Scholar
• Gervais F, Hebert L, Skamene E. Amyloid-enhancing factor: Production and response in amyloidosis-susceptible and resistant mouse strains. J Leukocyte Biol 1988; 43: 311–316
   PubMed Web of Science ®Google Scholar
• Hebert L, Gervais F. Apo-SAAl/Apo-SAA2 isotype ratios during casein-enhancing-factor-induced and amyloid-enhancing-factor-induced secondary amyloidosis in A/J and C57BL/6J mice. Scand J Immunol 1990; 31: 167–173
   PubMedGoogle Scholar
• Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidos is of Familial Mediterranean Fever. N Engl J Med 1986; 314: 1001
   PubMed Web of Science ®Google Scholar
• Kedar I, Greenwald M, Ravid M. Colchicine inhibition of the first phase of amyloid synthesis in experimental animals. Brit J Exp Pathol 1976; 57: 686
   Google Scholar
• Kedar I, Ravid M, Sohar E, Gafni J. Colchicine inhibition of casein-induced amyloidosis in mice. Isr J Med Sci 1974; 10: 130–136
   Google Scholar
• Kisilevsky R, Boudreau L, Foster D. Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy. Lab Invest 1983; 48: 60–67
   PubMed Web of Science ®Google Scholar
• Brandwein S R, Sipe J D, Skinner M, Cohen A S. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models: chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation. Lab Invest 1985; 52: 319–325
   PubMed Web of Science ®Google Scholar